Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…ry review to validate its off-label use. The treatment included hydrocortisone (100 mg), acetaminophen (1 g), and dexchlorpheniramine (5 mg), …
…eutic approaches are imperative for those who are refractory to blinatumomab and chimeric antigen receptor T (CAR-T) cell therapy. CAR-natur…
…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
…on, IFN-γ production, or activation marker expression. In vivo, BLINA monotherapy significantly reduced leukemia burden, but resulted…
…es induction chemotherapy, including dose-reduced pegaspargase (PEG-Asp), blinatumomab consolidative therapy and HSCT for post-inductio…
…Background Blinatumomab, inotuzumab or autologous anti-CD19 chimeric antigen receptor (…
…y in evaluating ADCC antibodies like Trastuzumab, Margetuximab, Rituximab and Blinatumomab. Collectively, the NCG-hIL2 and NCG-hIL15 mode…
…arlatamab, epcoritamab, glofitamab, mosunetuzumab, talquetamab, teclistamab, and elranatamab. Eligibility criteria were abstracted for excl…
…Background Bispecific T cell engager (BiTE), such as blinatumomab, has demonstrated significant clinical success in treating hema…